PCVX ▲ +0.7% - Vaxcyte, Inc.
$PCVX - Vaxcyte to Host Webcast and Conference Call to Present Topline Data from OPUS-1, the Pivotal Adult Phase 3 Trial of VAX-31, the Company’s 31-Valent Pneumococcal Conjugate Vaccine Candidate
04-OCT-2026 05:00 PM ET
Share this post
More filings for $PCVX
PCVX - Vaxcyte, Inc. - SEC Filing Update (06-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 6, 2026PCVX ▲ +7.9% - Vaxcyte, Inc.Nov 4, 2026PCVX ▲ +7.9% - Vaxcyte, Inc.Nov 4, 2026PCVX ▲ +9.4% - Vaxcyte, Inc.Oct 10, 2026PCVX ▼ -0.9% - Vaxcyte, Inc.Oct 7, 2026PCVX ▼ -9.8% - Vaxcyte, Inc.Oct 7, 2026
View full $PCVX filing history →💬 Comments
Loading comments…
Leave a comment